Evaluation the Effect of Sublingual Glutathione on the Quality of Life in COPD Patient by Using Saint George respiratory questionnaire

Authors

  • Ali H. Farag College of Pharmacy, Mustansiriyah University, Baghdad, Iraq
  • Wassan A. Abass College of Pharmacy, Mustansiriyah University, Baghdad, Iraq
  • Hyder S. Qassem College of Medicine, Maysan University, Maysan, Iraq

DOI:

https://doi.org/10.32947/ajps.v23i2.1015

Keywords:

Chronic obstructive pulmonary disease, Sublingual, Glutathione, Saint George respiratory questionnaire.

Abstract

Background: Chronic obstructive pulmonary disease (COPD)  is  a  chronic  inflammatory  disorder  of  the  airways associated  with  airway  narrowing  with  airflow  obstruction  leading to difficulty in breathing impair daily activity and cause poor quality of life. Patients  and  methods:  Fifty  patients whom  diagnosed with COPD are divided into   two  groups,  1st control group  includes  25 patients  assigned  to  receive  conventional  therapy of Formoterol fumarate 12 microgram inhaler twice daily,  and 2nd interventional group also includes  25  patients  assigned  to  receive  conventional  therapy with  (300 mg/ 2 times daily)   sublingual glutathione  for  two months. Saint George respiratory questionnaire (SGRQ) were  measured  before and after  first and second months after treatment  in  both  study groups. Aim  of  the  study: This  study  was  object to  assess the  changes  in quality of life by using SGRQ following sublingual glutathione supplements  therapy in COPD patients. Results and conclusion: After  two months  treatment ,  the  mean  values  of  SGRQ showed a significant  increase  compared  to  pre-treatment levels in  both  groups  (P<0.01).  There  was  highly  significant  improvement  in SGRQ in both  COPD  patients  groups after 2 months of treatment with much significant improvement in intervention group which may indicate the beneficial effects of adding glutathione sublingually administered supplements in COPD patients conventional therapeutic regiment.

References

Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DM, Han M, Varela MV. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. European Respiratory Journal. 2019 May 1;53(5). DOI: https://doi.org/10.1183/13993003.00164-2019

Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine. 2006 Nov 28;3(11):e442. DOI: https://doi.org/10.1371/journal.pmed.0030442

Kc R, Shukla SD, Gautam SS, Hansbro PM, O’Toole RF. The role of environmental exposure to non-cigarette smoke in lung disease. Clinical and translational medicine. 2018 Dec;7(1):1-2. DOI: https://doi.org/10.1186/s40169-018-0217-2

Meiners S, Eickelberg O, Königshoff M. Hallmarks of the ageing lung. European Respiratory Journal. 2015 Mar 1;45(3):807-27. DOI: https://doi.org/10.1183/09031936.00186914

Barnes PJ. Pulmonary diseases and ageing. Biochemistry and Cell Biology of Ageing: Part II Clinical Science. 2019:45-74. DOI: https://doi.org/10.1007/978-981-13-3681-2_3

Almukhtar HM, Faisal IM, Merkhan MM. Short-term treatment with Atorvastatin selectively decreases Lymphocyte count. Research Journal of Pharmacy and Technology. 2022 Feb 1;15(2):689-94. DOI: https://doi.org/10.52711/0974-360X.2022.00114

Almukhtar HM, Faisal IM, Merkhan MM. Acute effect of atorvastatin in comparison with rosuvastatin on glucose homeostasis in hypercholesteremic patients. Pharmacology. 2021;25:25-34.

Almukhtar HM, Faisal IM, Merkhan MM. Effects of statins on platelet count in hyperlipidemic patients. International Journal of Pharmaceutical Research. 2020 Apr;12(2):2640-4. DOI: https://doi.org/10.31838/ijpr/2020.12.02.357

Merkhan MM. The effects of glibenclamide on thyroid function tests in type 2 diabetic patients. Iraq J Pharm Vol. 2013;13(2). DOI: https://doi.org/10.33899/iphr.2013.86556

Younis HY, Thanoon IA, Fadhil NN, Merkhan MM. Effect of Zinc as an Add-On to Metformin Therapy on Glycemic control, Serum Insulin, and C-peptide Levels and Insulin Resistance in Type 2 Diabetes Mellitus Patient. Research Journal of Pharmacy and Technology. 2022 Mar 24;15(3):1184-8. DOI: https://doi.org/10.52711/0974-360X.2022.00198

Merkhan MM. Effect of metformin, glibenclamide and insulin on lipid profile in type 2 diabetic patients. Tikret Journal of Pharmaceutical Sciences. 2013;9(2).

Younis HY, Imad A. Effect of zinc as an add on to metformin therapy on serum lipid profile and uric acid in type 2 diabetes mellitus patients. Curr topics in Pharmacology. 2021;25.

Alchalaby LA, Zainal AA, Abdulrazzaq GM, Merkhan MM. Allopurinol modulated serum troponin level in renal stone patients. Archivos Venezolanos de Farmacologia y Terapéutica. 2022;41(2):101-4.

Faisal IM, Merkhan MM, Almukhtar HM. Effect of chronic Allopurinol therapy on Thyroid function in patients with urate stones. Journal of Advanced Pharmacy Education & Research| Oct-Dec. 2020;10(4):5.

Abdulrazzaq G, Khalaf MM, Merkhan MM. Allopurinol therapy impairs lipid metabolism in patients with renal stone. Pharmacology. 2006;1:1.

Mahmood E, Merkhan MM, Mustafa YF. Safety and Efficacy of Proton-Pump Inhibitors are Relevant to their Distinctive Chemical Structures and Physicochemical Properties.

Abdullah E, Dhiaa S, Saleh K, Merkhan M. Effect of esomeprazole on lipid profile in patients with peptic ulcer. Pharmacia. 2021 Aug 17;68:613. DOI: https://doi.org/10.3897/pharmacia.68.e70292

Merkhan MM, Abdullah E, Althanoon Z. Effect of Esomeprazole on serum creatinine and urea in patients with Peptic Ulcer. Research Journal of Pharmacy and Technology. 2022;15(1):160-4. DOI: https://doi.org/10.52711/0974-360X.2022.00026

Couto N, Malys N, Gaskell SJ, Barber J. Partition and turnover of glutathione reductase from Saccharomyces cerevisiae: a proteomic approach. Journal of proteome research. 2013 Jun 7;12(6):2885-94. DOI: https://doi.org/10.1021/pr4001948

Jones PW. St George’s respiratory questionnaire for COPD patients (SGRQ-C). Structure. 2008;44:1-7.

Paap MC, Lange L, van der Palen J, Bode C. Using the Three-Step Test Interview to understand how patients perceive the St. George’s Respiratory Questionnaire for COPD patients (SGRQ-C). Quality of Life Research. 2016 Jun;25:1561-70. DOI: https://doi.org/10.1007/s11136-015-1192-3

Hassali MA, Harun SN, Abbas S, Muneswarao J, Ali IA, Hussain R. Validation and clinical interpretation of the St George’s respiratory questionnaire for COPD (SGRQ-C) after adaptation to Malaysian language and culture, in patients with COPD. Health and quality of life outcomes. 2020 Dec;18(1):1-2. DOI: https://doi.org/10.1186/s12955-020-01393-1

Jones PW, Spencer S, Adie S. St George’s respiratory questionnaire manual. St Georges University of London. 2009 Jun.

Panahi Y, Ghanei M, Hajhashemi A, Sahebkar A. Effects of curcuminoids-piperine combination on systemic oxidative stress, clinical symptoms and quality of life in subjects with chronic pulmonary complications due to sulfur mustard: a randomized controlled trial. Journal of dietary supplements. 2016 Jan 2;13(1):93-105. DOI: https://doi.org/10.3109/19390211.2014.952865

Moussa SB, Rouatbi S, Saad HB. Incapacity, handicap, and oxidative stress markers of male smokers with and without COPD. Respiratory Care. 2016 May 1;61(5):668-79. DOI: https://doi.org/10.4187/respcare.04420

Zinellu E, Zinellu A, Fois AG, Fois SS, Piras B, Carru C, Pirina P. Reliability and usefulness of different biomarkers of oxidative stress in chronic obstructive pulmonary disease. Oxidative Medicine and Cellular Longevity. 2020 Oct;2020. DOI: https://doi.org/10.1155/2020/4982324

Arif IS, Kamal YM, Raoof IB. Nrf2 as a modulator of oxidative stress. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2021;21(4):17-23. DOI: https://doi.org/10.32947/ajps.v21i4.798

Mahdi FM, Alabbassi MG, Al-Ezzi MI. Protective Effect of Co Q10 and Candesartan on Bleomyycin Induced Lung Fibrosis in Rats. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2021;21(1):16-25. DOI: https://doi.org/10.32947/ajps.v21i1.787

Shephard MT, Merkhan MM, Forsyth NR. Human Mesenchymal Stem Cell Secretome Driven T Cell Immunomodulation Is IL-10 Dependent. International Journal of Molecular Sciences. 2022 Nov 6;23(21):13596. DOI: https://doi.org/10.3390/ijms232113596

Chen L, Merkhan MM, Forsyth NR, Wu P. Chorionic and amniotic membrane-derived stem cells have distinct, and gestational diabetes mellitus independent, proliferative, differentiation, and immunomodulatory capacities. Stem Cell Research. 2019 Oct 1;40:101537. DOI: https://doi.org/10.1016/j.scr.2019.101537

Forsyth NR, Steeg R, Ahmad M, Al Zubaidi M, Al-Jumaily R, Merkhan M, Dale T. Mimicking Physiological Oxygen in Cell Cultures. InCell Culture Technology 2018 (pp. 129-137). Springer, Cham. DOI: https://doi.org/10.1007/978-3-319-74854-2_8

Merkhan MM, Shephard MT, Forsyth NR. Physoxia alters human mesenchymal stem cell secretome. Journal of Tissue Engineering. 2021 Oct;12:20417314211056132. DOI: https://doi.org/10.1177/20417314211056132

Alzamily AA, Al-Delfi MN, Al-Barqaw AR. A role for inflammatory IL-6 in the development of coronary artery disease: a case control study at Al-Qadisiyah governorate, Iraq. Military Medical Science Letter, 91(4), 293-304. DOI: https://doi.org/10.31482/mmsl.2022.005

Alzamily AA, Obaid KM, Al-Azzawi B. Metformin may ameliorate inflammatory events of IL-18 in some inflammatory conditions. 2021; Military Medical Science Letter, 91(3), 170-181. DOI: https://doi.org/10.31482/mmsl.2021.039

Downloads

Published

2023-05-22

How to Cite

Ali H. Farag, Wassan A. Abass, & Hyder S. Qassem. (2023). Evaluation the Effect of Sublingual Glutathione on the Quality of Life in COPD Patient by Using Saint George respiratory questionnaire . Al Mustansiriyah Journal of Pharmaceutical Sciences, 23(2), 140–146. https://doi.org/10.32947/ajps.v23i2.1015